ProShares UltraShort Nasdaq Biotechnology (BIS) Chart & Stock Price History $15.51 +0.43 (+2.85%) Closing price 08/5/2025 03:59 PM EasternExtended Trading$15.40 -0.12 (-0.74%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartDividendHoldingsOptions ChainOwnershipShort InterestTrendsBuy This Stock ProShares UltraShort Nasdaq Biotechnology Stock Price Performance The ProShares UltraShort Nasdaq Biotechnology (BIS) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has decreased 4.38%, with a year-to-date return of -14.73%. In the past month, the fund has decreased 7.31%, reflecting recent market activity. As of the latest close, ProShares UltraShort Nasdaq Biotechnology traded at $15.51 with a market cap of $2.64 million and volume of 14,502 shares. Five years ago, the fund traded at a split-adjusted price of $31.56, representing a 50.86% decrease over that period. At the time, it had a market cap of $12.20 million and a volume of 267,930 shares. Receive BIS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.21%1 Month Performance-7.31%3 Month Performance-23.40%Year-To-Date Performance-14.73%1 Year Performance-4.38%5 Year Performance-50.86% BIS Stock Chart for Wednesday, August, 6, 2025 BIS Chart by TradingView ProShares UltraShort Nasdaq Biotechnology Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/05/2025$15.08$15.51+2.85%$15.60$15.3414,502 shs$2.64 million08/04/2025$15.70$15.08-3.95%$15.60$15.074,268 shs$2.56 million08/01/2025$15.87$15.70-1.07%$16.07$15.683,163 shs$2.67 million07/31/2025$15.62$15.87+1.60%$15.93$15.364,566 shs$2.70 million07/30/2025$15.68$15.62-0.38%$15.74$15.2512,103 shs$2.66 million07/29/2025$15.60$15.68+0.51%$15.72$15.623,550 shs$2.67 million07/28/2025$15.21$15.60+2.56%$15.63$15.3113,410 shs$2.65 million07/25/2025$15.21$15.21$15.47$15.166,184 shs$2.59 million07/24/2025$15.11$15.21+0.66%$15.29$15.078,733 shs$2.59 million07/23/2025$15.69$15.11-3.70%$15.51$15.0417,489 shs$2.57 million Get the Latest News and Ratings for BIS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 07/22/2025$16.42$15.69-4.45%$16.27$15.6811,621 shs$2.67 million07/21/2025$16.32$16.42+0.61%$16.47$16.1018,856 shs$2.79 million07/18/2025$15.86$16.32+2.90%$16.37$15.7912,877 shs$2.77 million07/17/2025$15.96$15.86-0.63%$15.99$15.761,936 shs$2.70 million07/16/2025$16.53$15.96-3.45%$16.26$15.9120,290 shs$2.71 million07/15/2025$15.85$16.53+4.29%$16.57$15.9016,040 shs$2.81 million07/14/2025$16.21$15.85-2.20%$16.24$15.852,572 shs$2.69 million07/11/2025$15.73$16.21+3.03%$16.27$16.046,069 shs$2.76 million07/10/2025$16.03$15.73-1.87%$16.19$15.716,582 shs$2.67 million07/09/2025$16.92$16.03-5.26%$16.66$16.0018,491 shs$2.73 million07/08/2025$17.22$16.92-1.74%$17.01$16.6312,332 shs$2.88 million07/07/2025$16.73$17.22+2.90%$17.43$16.7129,573 shs$2.93 million Related Companies JPMorgan Healthcare Leaders ETF Stock Chart T. Rowe Price Health Care ETF Stock Chart First Trust Nasdaq Pharmaceuticals ETF Stock Chart Horizon Kinetics Medical ETF Stock Chart Invesco Nasdaq Biotechnology ETF Stock Chart Global X HealthTech ETF Stock Chart ProShares Ultra Nasdaq Biotechnology Stock Chart F/m Emerald Life Sciences Innovation ETF Stock Chart Invesco Dorsey Wright Healthcare Momentum ETF Stock Chart Invesco S&P SmallCap Health Care ETF Stock Chart Receive BIS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIS) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraShort Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIS Stock Alerts